Page last updated: 2024-11-10

ent-8-hydroxylabda-13(16),14-diene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ent-8-hydroxylabda-13(16),14-diene: thromboxane B2 and leukotriene B4 antagonist isolated from the Spanish herb Sideritis javalambrensis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
SideritisgenusA plant genus of the family LAMIACEAE that contains isoscutellarein-7-O-(allosyl(1-2)glucoside).[MeSH]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Sideritis javalambrensisspecies[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]

Cross-References

ID SourceID
PubMed CID3080960
MeSH IDM0235871

Synonyms (10)

Synonym
ent-8-hydroxylabda-13(16),14-diene
2-naphthalenol, decahydro-2,5,5,8a-tetramethyl-1-(3-methylene-4-pentenyl)-, (1r-(1alpha,2alpha,4aalpha,8abeta))-
89900-49-2
(1r-(1alpha,2alpha,4aalpha,8abeta))-decahydro-2,5,5,8a-tetramethyl-1-(3-methylene-4-pentenyl)-2-naphthalenol
labdane f2
(1r,2s,4ar,8ar)-2,5,5,8a-tetramethyl-1-(3-methylidenepent-4-enyl)-3,4,4a,6,7,8-hexahydro-1h-naphthalen-2-ol
(1r,2s,4ar,8ar)-2,5,5,8a-tetramethyl-1-(3-methylenepent-4-en-1-yl)decahydronaphthalen-2-ol
DTXSID801009039
2,5,5,8a-tetramethyl-1-(3-methylidenepent-4-en-1-yl)decahydronaphthalen-2-ol
AKOS040746970
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]